186 related articles for article (PubMed ID: 25081754)
1. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Lee JJ; Granter SR; Laga AC; Saavedra AP; Zhan Q; Guo W; Xu S; Murphy GF; Lian CG
Mod Pathol; 2015 Feb; 28(2):218-29. PubMed ID: 25081754
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.
Saab J; Santos-Zabala ML; Loda M; Stack EC; Hollmann TJ
Am J Dermatopathol; 2018 Apr; 40(4):259-264. PubMed ID: 28654463
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.
Mentrikoski MJ; Ma L; Pryor JG; McMahon LA; Yang Q; Spaulding BO; Scott GA; Wang HL; Xu H
Mod Pathol; 2009 Dec; 22(12):1582-7. PubMed ID: 19734845
[TBL] [Abstract][Full Text] [Related]
6. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
[TBL] [Abstract][Full Text] [Related]
7. FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
J Cutan Pathol; 2023 Mar; 50(3):247-258. PubMed ID: 36454046
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.
Dalton SR; Gerami P; Kolaitis NA; Charzan S; Werling R; LeBoit PE; Bastian BC
Am J Surg Pathol; 2010 Feb; 34(2):231-7. PubMed ID: 20087158
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining for the tumour suppressor gene p16 product is a useful marker to differentiate melanoma metastasis from lymph-node nevus.
Mihic-Probst D; Saremaslani P; Komminoth P; Heitz PU
Virchows Arch; 2003 Dec; 443(6):745-51. PubMed ID: 14576937
[TBL] [Abstract][Full Text] [Related]
10. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
11. Nodal blue nevus: a pitfall in lymph node biopsies.
Dohse L; Ferringer T
J Cutan Pathol; 2010 Jan; 37(1):102-4. PubMed ID: 19615001
[TBL] [Abstract][Full Text] [Related]
12. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
See SHC; Finkelman BS; Yeldandi AV
Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes.
Gambichler T; Scholl L; Stücker M; Bechara FG; Hoffmann K; Altmeyer P; Othlinghaus N
Am J Clin Pathol; 2013 May; 139(5):566-73. PubMed ID: 23596107
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
Lezcano C; Pulitzer M; Moy AP; Hollmann TJ; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Apr; 44(4):503-508. PubMed ID: 31633488
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Rodić N; Zampella J; Sharma R; Burns KH; Taube JM
J Cutan Pathol; 2015 Nov; 42(11):807-14. PubMed ID: 26239102
[TBL] [Abstract][Full Text] [Related]
17. Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivity.
Piana S; Tagliavini E; Ragazzi M; Zanelli M; Zalaudek I; Ciarrocchi A; Valli R
Pathol Res Pract; 2015 May; 211(5):381-8. PubMed ID: 25661066
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of ectopic nodal inclusions with special emphasis on nodal nevi.
Müller CSL; Müller SG; Vogt T; Pföhler C
J Dtsch Dermatol Ges; 2021 Aug; 19(8):1145-1157. PubMed ID: 34390159
[TBL] [Abstract][Full Text] [Related]
19. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
[TBL] [Abstract][Full Text] [Related]
20. Case of nodal nevus with melanocytic cell aggregates in the lymphatic hilum: A potential diagnostic pitfall that requires differentiation from metastatic melanoma of the lymph node.
Ogawa K; Kobayashi N; Miyagawa F; Nakai T; Fukumoto T; Mitsui Y; Arai E; Asada H
J Dermatol; 2020 Jun; 47(6):e242-e244. PubMed ID: 32201978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
